Pembrolizumab monotherapy versus chemotherapy for treatment of advanced urothelial carcinoma with disease progression during or following platinum‐containing chemotherapy. A Cochrane Rapid Review

BACKGROUND: The use of systemic immunotherapy targets is emerging as an important treatment option for metastatic urothelial carcinoma, particularly for patients who cannot tolerate or who fail cisplatin‐based chemotherapy. One such target is the inhibition of the checkpoint protein programmed cell...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cochrane Database Syst Rev
Main Authors: Narayan, Vikram, Kahlmeyer, Andreas, Dahm, Philipp, Skoetz, Nicole, Risk, Michael C, Bongiorno, Connie, Patel, Neil, Hwang, Eu Chang, Jung, Jae Hung, Gartlehner, Gerald, Kunath, Frank
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Ltd 2018
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6513246/
https://ncbi.nlm.nih.gov/pubmed/30036453
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD012838.pub2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados